logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Pain

    FiltersReset Filters
    94 results
    • acetaminophen

      (ACETAMINOPHEN)
      Fresenius Kabi USA, LLC
      Usage: Acetaminophen Injection is indicated for managing mild to moderate pain, moderate to severe pain with combined opioid use, and reducing fever in adults and pediatric patients aged 2 years and older.
    • acetaminophen and codeine phosphate

      (Acetaminophen and Codeine Phosphate)
      Sun Pharmaceutical Industries, Inc.
      Usage: Acetaminophen and Codeine Phosphate Tablets are indicated for managing mild to moderate pain when alternative treatments are inadequate. Due to addiction and misuse risks, they should be reserved for patients who poorly respond to non-opioid analgesics or cannot tolerate them.
    • butorphanol tartrate

      (Butorphanol Tartrate)
      Apotex Corp.
      Usage: Butorphanol tartrate nasal spray is indicated for managing severe pain that requires opioid analgesics when alternative treatments are insufficient. It should be reserved for patients who cannot tolerate or achieve adequate relief from non-opioid options, and long-term use is not recommended unless necessary.
    • clobetasol propionate

      (CLOBETASOL PROPIONATE)
      Eyenovia, Inc.
      Usage: BYQLOVI is indicated for treating post-operative inflammation and pain after ocular surgery.
    • demerol

      (MEPERIDINE HYDROCHLORIDE)
      Hospira, Inc.
      Usage: DEMEROL Injection is indicated for preoperative medication, anesthesia support, obstetrical analgesia, and managing severe pain that alternative treatments cannot adequately address. It should be reserved for patients who cannot tolerate or benefit from non-opioid options due to the risk of addiction and other complications.
    • diclofenac potassium

      (diclofenac potassium)
      Marlex Pharmaceuticals Inc
      Usage: Diclofenac potassium tablets are indicated for treating primary dysmenorrhea, relieving mild to moderate pain, and alleviating signs and symptoms of osteoarthritis and rheumatoid arthritis. The lowest effective dose should be used for the shortest duration to minimize risks.
    • diflunisal

      (Diflunisal)
      Zydus Lifesciences Limited
      Usage: Diflunisal tablets are indicated for the symptomatic treatment of mild to moderate pain, osteoarthritis, and rheumatoid arthritis. Use the lowest effective dose for the shortest duration based on individual patient needs, considering potential benefits and risks.
    • diflunisal

      (Diflunisal)
      Chartwell RX, LLC
      Usage: Diflunisal tablets are indicated for the symptomatic treatment of mild to moderate pain, osteoarthritis, and rheumatoid arthritis. Use the lowest effective dose for the shortest duration appropriate for individual treatment goals.
    • dilaudid

      (hydromorphone hydrochloride)
      Rhodes Pharmaceuticals L.P.
      Usage: DILAUDID Oral Solution and Tablets are indicated for managing severe pain requiring opioid analgesics when alternative treatments are inadequate. Use is limited due to risks of addiction and misuse, and they should only be prescribed when non-opioid options are ineffective or intolerable. Extended use is discouraged.
    • dilaudid

      (Hydromorphone hydrochloride)
      Fresenius Kabi USA, LLC
      Usage: DILAUDID INJECTION is indicated for managing severe pain requiring an opioid analgesic when other treatments are insufficient. It should be reserved for patients where non-opioid options have been ineffective or poorly tolerated due to the risk of addiction and misuse.
    • ...